Fiber type-specific nitric oxide protects oxidative myofibers against cachectic stimuli.
| dc.contributor.author | Yu, Zengli | |
| dc.contributor.author | Li, Ping | |
| dc.contributor.author | Zhang, Mei | |
| dc.contributor.author | Hannink, Mark | |
| dc.contributor.author | Stamler, Jonathan S | |
| dc.contributor.author | Yan, Zhen | |
| dc.coverage.spatial | United States | |
| dc.date.accessioned | 2011-06-21T17:31:23Z | |
| dc.date.issued | 2008-05-07 | |
| dc.description.abstract | Oxidative skeletal muscles are more resistant than glycolytic muscles to cachexia caused by chronic heart failure and other chronic diseases. The molecular mechanism for the protection associated with oxidative phenotype remains elusive. We hypothesized that differences in reactive oxygen species (ROS) and nitric oxide (NO) determine the fiber type susceptibility. Here, we show that intraperitoneal injection of endotoxin (lipopolysaccharide, LPS) in mice resulted in higher level of ROS and greater expression of muscle-specific E3 ubiqitin ligases, muscle atrophy F-box (MAFbx)/atrogin-1 and muscle RING finger-1 (MuRF1), in glycolytic white vastus lateralis muscle than in oxidative soleus muscle. By contrast, NO production, inducible NO synthase (iNos) and antioxidant gene expression were greatly enhanced in oxidative, but not in glycolytic muscles, suggesting that NO mediates protection against muscle wasting. NO donors enhanced iNos and antioxidant gene expression and blocked cytokine/endotoxin-induced MAFbx/atrogin-1 expression in cultured myoblasts and in skeletal muscle in vivo. Our studies reveal a novel protective mechanism in oxidative myofibers mediated by enhanced iNos and antioxidant gene expression and suggest a significant value of enhanced NO signaling as a new therapeutic strategy for cachexia. | |
| dc.description.version | Version of Record | |
| dc.identifier | ||
| dc.identifier.eissn | 1932-6203 | |
| dc.identifier.uri | ||
| dc.language | eng | |
| dc.language.iso | en_US | |
| dc.publisher | Public Library of Science (PLoS) | |
| dc.relation.ispartof | PLoS One | |
| dc.relation.isversionof | 10.1371/journal.pone.0002086 | |
| dc.relation.journal | Plos One | |
| dc.subject | Animals | |
| dc.subject | Antioxidants | |
| dc.subject | Atrophy | |
| dc.subject | Cachexia | |
| dc.subject | Endotoxins | |
| dc.subject | Gene Expression Regulation | |
| dc.subject | Glycolysis | |
| dc.subject | Mice | |
| dc.subject | Molecular Sequence Data | |
| dc.subject | Muscle Fibers, Skeletal | |
| dc.subject | Muscle, Skeletal | |
| dc.subject | Nitric Oxide | |
| dc.subject | Oxidative Stress | |
| dc.subject | Reactive Oxygen Species | |
| dc.subject | S-Nitrosoglutathione | |
| dc.title | Fiber type-specific nitric oxide protects oxidative myofibers against cachectic stimuli. | |
| dc.title.alternative | ||
| dc.type | Journal article | |
| duke.date.pubdate | 2008-5-7 | |
| duke.description.issue | 5 | |
| duke.description.volume | 3 | |
| pubs.author-url | ||
| pubs.begin-page | e2086 | |
| pubs.issue | 5 | |
| pubs.organisational-group | Clinical Science Departments | |
| pubs.organisational-group | Duke | |
| pubs.organisational-group | Medicine | |
| pubs.organisational-group | Medicine, Pulmonary, Allergy, and Critical Care Medicine | |
| pubs.organisational-group | School of Medicine | |
| pubs.publication-status | Published online | |
| pubs.volume | 3 |